The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

The medications seem to dampen the effects of drugs ranging from nicotine to alcohol—but scientists haven’t been able to ...

A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...

Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...